Summary: The basis of cerulenin resistance of Candida albicans strains 4918-2 and 4918-10 has been investigated. Parasexual genetic analyses established that cerulenin resistance to concentrations of at least 5 μg ml-1 is dominant in both strains. The results also showed that strain 4918-2 is heterozygous for resistance, while the change from resistance to sensitivity of strain 4918-10 is reversible. Experiments to define the mechanism(s) responsible for resistance focused on cerulenin uptake and fatty-acid synthase activity. Cerulenin uptake by strains 4918-2 and 4918-10 was 24% of that of the wild-type (strain 4918). Uptake was restored in UV-induced cerulenin-sensitive segregants of strains 4918-2 and 4918-10, and varied from 63% to 200% of parental values. Fatty-acid synthase from strains 4918-2 and 4918-10 was resistant to cerulenin as judged by differences in the inactivation of the enzyme by the agent. However, inactivation kinetics of fatty-acid synthase of cerulenin-sensitive segregants did not revert to the parental inactivation profile. Further investigation showed that nine out of ten segregants were resistant to cerulenin at concentrations between 1 and 4 μg ml-1 while strain 4918 was sensitive to cerulenin at all concentrations tested. Thus, the results suggest that alteration of fatty-acid synthase and changes in permeability contribute to total cerulenin resistance of each strain.
CalderoneR.A.,
CihlarR.L.,
LeeD.D.S.,
HobergK.,
ScheldM.1986; Yeast adhesion in the pathogenesis of endocarditis due to Candida albicans-, studies with adherence-negative mutants.. J Infect Dis 152:710–715
CihlarR.L.,
HobergK.,
CalderoneR.A.1984; Isolation of cerulenin-resistant mutants of Candida albicans.
. In Microbiology-1984 pp. 148–149LevineL.,
SchlesingerD.
Edited by Washington, DC: American Society for Microbiology;
De BernardisF.,
AdrianiD.,
LorenziniR.,
PontieuE.,
CarrubaG.,
CassoneA.1993; Filamentous growth and elevated vagino- pathic potential of a nongerminative variant of Candida albicans expressing low virulence in systemic infection.. Infect Immun 61:1500–1508
HostetterM.K.1994; Adhesions and ligands involved in the interaction of Candida spp. with epithelial and endothelial surfaces.. Clin Microbiol Rev 7:29–42
LehrerN.,
SegalE.,
CihlarR.L.,
CalderonR.A.1986; Pathogenesis of vaginal candidiasis: a mutant which has reduced ability to adhere in vitro.. J Med Vet Mycol 24:127–131
MalavasicM.J.,
McElhaney-FeserG.E.,
SouthardS.B.,
CihlarR.L.1991; Phenotypic variation of a virulent Candida albicans strain and two spontaneous, relatively avirulent mutant strain derivatives.. J Med Vet Mycol 29:145–155
ManningM.,
MitchellT.G.1980; Strain variation and morphogenesis of yeast and mycelial-phase Candida albicans in low sulfate, synthetic medium.. J Bacteriol 142:714–719
McElhaney-FeserG.E.,
CihlarR.L.1994; Purification and characterization of fatty acid synthase from Candida albicans, strain 4918, and two derived spontaneous cerulenin-resistant mutants.. J Med Vet Mycol 32:13–20
OllertM.W.,
WadsworthE.,
CalderoneR.A.1990; Reduced expression of the functionally active complement receptor for iC3b on an avirulent mutant of Candida albicans.. Infect Immun 58:909–913
RossI.K.,
De BernardisF.,
EmersonG.W.,
CassoneA.,
SullivanP.A.1990; The secreted aspartate proteinase of Candida albicans-, physiology of secretion and virulence of a proteinase deficient mutant.. J Gen Microbiol 136:687–694
SaxenaA.,
McElhaney-FeserG.E.,
CihlarR.L.1990; Mannan composition of the hyphal form of two relatively avirulent mutants of Candida albicans.. Infect Immun 58:2061–2066